New Key Statistics Module, Z-Score and F-Score
OSL:BGBIO Key Ratios
| Market Cap kr M | 488.59 |
| Enterprise Value kr M | 333.04 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.65 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | -- |
| EPS (TTM) kr | -0.87 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 35.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.75 |
| EV-to-EBITDA | -1.75 |
| PEG | -- |
| Shares Outstanding M | 3,908.71 |
| Net Margin (%) | -53,785.88 |
| Operating Margin % | -54,186.72 |
| Pre-tax Margin (%) | -53,785.88 |
| Quick Ratio | 3.71 |
| Current Ratio | 3.71 |
| ROA % (ttm) | -111.33 |
| ROE % (ttm) | -163.15 |
| ROIC % (ttm) | -749.73 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.30 |
OSL:BGBIO Number of Guru Trades
OSL:BGBIO Volume of Guru Trades
Gurus Latest Trades with OSL:BGBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OSL:BGBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers